世界の下痢同伴過敏性腸症候群(IBS-D)治療薬市場レポート2020年

【英語タイトル】Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB7522)・商品コード:QYR21FB7522
・発行会社(調査会社):QYResearch
・発行日:2021年1月(※2024年版があります。お問い合わせください)
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界の下痢同伴過敏性腸症候群(IBS-D)治療薬市場について種類別(エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン、ヒヨスチアミン)、用途別(病院、診療所、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・下痢同伴過敏性腸症候群(IBS-D)治療薬市場の概要
・世界の主要地域別下痢同伴過敏性腸症候群(IBS-D)治療薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の下痢同伴過敏性腸症候群(IBS-D)治療薬市場規模2015-2026:種類別(エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン、ヒヨスチアミン)
・世界の下痢同伴過敏性腸症候群(IBS-D)治療薬市場規模2015-2026:用途別(病院、診療所、その他)
・下痢同伴過敏性腸症候群(IBS-D)治療薬のアメリカ市場規模2015-2020
・下痢同伴過敏性腸症候群(IBS-D)治療薬のヨーロッパ市場規模2015-2020
・下痢同伴過敏性腸症候群(IBS-D)治療薬の中国市場規模2015-2020
・下痢同伴過敏性腸症候群(IBS-D)治療薬の日本市場規模2015-2020
・下痢同伴過敏性腸症候群(IBS-D)治療薬の東南アジア市場規模2015-2020
・下痢同伴過敏性腸症候群(IBS-D)治療薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・下痢同伴過敏性腸症候群(IBS-D)治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・下痢同伴過敏性腸症候群(IBS-D)治療薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Rifaximin (Xifaxan) is an antibiotic medication for IBS-D that works by reducing or altering gut bacteria, and it can improve symptoms of bloating and diarrhea after a 10 to 14 day course of treatment. Some patients require retreatment at higher doses for symptom relief.

Market Analysis and Insights: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Scope and Market Size
The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is segmented into
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine

Segment by Application, the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is segmented into
Hospitals
Clinics
Others

The Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Analysis
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs business, the date to enter into the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs product introduction, recent developments, etc.

The major vendors covered:
Astellas Pharmaceuticals
Actavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals Ltd
AstraZenenca

【レポートの目次】

1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Scope
1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
1.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2020-2026)
1.2.2 Eluxadoline
1.2.3 Alosetron
1.2.4 Rifaximin
1.2.5 Loperamide
1.2.6 Diphenoxylate + Atropine
1.2.7 Dicyclomine and Hyoscyamine
1.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Application
1.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Trends (2015-2026)

2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimate and Forecast by Region
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2015-2026)
2.4.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2015-2026)
2.4.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Estimates and Projections (2015-2026)
3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Competition Landscape by Players
3.1 Global Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players by Sales (2015-2020)
3.2 Global Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players by Revenue (2015-2020)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs as of 2019)
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players (Opinion Leaders)
4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2015-2020)
4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Type (2021-2026)
5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Application
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Application (2015-2020)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Application (2021-2026)

6 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
6.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
6.2 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
6.3 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)

7 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)

8 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
8.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
8.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
8.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)

9 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
9.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)

10 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
10.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)

11 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures
11.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
11.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
11.3 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business
12.1 Astellas Pharmaceuticals
12.1.1 Astellas Pharmaceuticals Corporation Information
12.1.2 Astellas Pharmaceuticals Business Overview
12.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.1.5 Astellas Pharmaceuticals Recent Development
12.2 Actavis
12.2.1 Actavis Corporation Information
12.2.2 Actavis Business Overview
12.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.2.5 Actavis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Business Overview
12.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Salix Pharmaceuticals Ltd
12.5.1 Salix Pharmaceuticals Ltd Corporation Information
12.5.2 Salix Pharmaceuticals Ltd Business Overview
12.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.5.5 Salix Pharmaceuticals Ltd Recent Development
12.6 AstraZenenca
12.6.1 AstraZenenca Corporation Information
12.6.2 AstraZenenca Business Overview
12.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
12.6.5 AstraZenenca Recent Development

13 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Analysis
13.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
13.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
14.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers

15 Market Dynamics
15.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trends
15.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Opportunities and Drivers
15.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Challenges
15.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Region (2015-2020)
Table 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Region (2015-2020)
Table 8. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (K MT) of Key Companies (2015-2020)
Table 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Company (2015-2020)
Table 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Company (2015-2020)
Table 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs as of 2019)
Table 17. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players
Table 22. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Type (2015-2020)
Table 23. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Type (2015-2020)
Table 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (K MT) by Type (2015-2020)
Table 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Type (2021-2026)
Table 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2021-2026)
Table 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (K MT) by Type (2021-2026)
Table 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Application (2015-2020)
Table 31. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Application (2015-2020)
Table 32. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (K MT) by Application (2015-2020)
Table 34. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Application (2021-2026)
Table 35. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Application (2021-2026)
Table 36. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Application (2021-2026)
Table 38. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (K MT) by Application (2021-2026)
Table 39. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Company (2015-2020)
Table 40. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Type (2015-2020)
Table 42. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Application (2015-2020)
Table 44. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Company (2015-2020)
Table 46. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Type (2015-2020)
Table 48. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Application (2015-2020)
Table 50. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
Table 51. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Company (2015-2020)
Table 52. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
Table 53. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Type (2015-2020)
Table 54. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
Table 55. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Application (2015-2020)
Table 56. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Company (2015-2020)
Table 58. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Type (2015-2020)
Table 60. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Application (2015-2020)
Table 62. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)
Table 69. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Company (2015-2020)
Table 70. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2015-2020)
Table 71. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Type (2015-2020)
Table 72. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2015-2020)
Table 73. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) by Application (2015-2020)
Table 74. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020)
Table 75. Astellas Pharmaceuticals Corporation Information
Table 76. Astellas Pharmaceuticals Description and Business Overview
Table 77. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 79. Astellas Pharmaceuticals Recent Development
Table 80. Actavis Corporation Information
Table 81. Actavis Description and Business Overview
Table 82. Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 84. Actavis Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 89. Pfizer Recent Development
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 94. GlaxoSmithKline Recent Development
Table 95. Salix Pharmaceuticals Ltd Corporation Information
Table 96. Salix Pharmaceuticals Ltd Description and Business Overview
Table 97. Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 99. Salix Pharmaceuticals Ltd Recent Development
Table 100. AstraZenenca Corporation Information
Table 101. AstraZenenca Description and Business Overview
Table 102. AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 104. AstraZenenca Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Table 108. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers List
Table 109. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Key Trends
Table 110. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Opportunities and Drivers
Table 111. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture
Figure 2. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Others Examples
Figure 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Market Share by Revenue in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 2015 & 2019
Figure 27. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2019
Figure 33. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2019
Figure 34. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2019
Figure 35. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2019
Figure 36. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application in 2019
Figure 37. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2019
Figure 38. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2019
Figure 39. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application in 2019
Figure 40. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2019
Figure 41. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2019
Figure 42. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application in 2019
Figure 46. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2019
Figure 47. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2019
Figure 48. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 51. Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 52. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


【掲載企業】

Astellas Pharmaceuticals、Actavis、Pfizer、GlaxoSmithKline、Salix Pharmaceuticals Ltd、AstraZenenca

★調査レポート[世界の下痢同伴過敏性腸症候群(IBS-D)治療薬市場レポート2020年] (コード:QYR21FB7522)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の下痢同伴過敏性腸症候群(IBS-D)治療薬市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆